Short Description
Quantifies acetylcholine, a primary neurotransmitter.
Development Stage
Research-Grade Metabolic Assay Development
Description
Designed for neurobiology research, the OXPHOSight™ Acetylcholine Assay Kit is indispensable for validating neuroactive compounds that modulate cholinergic signaling pathways. This assay provides the sensitivity needed to investigate neurotransmitter dynamics in Alzheimer's disease models and neuromuscular disorder studies. By facilitating the screening of acetylcholinesterase inhibitors and receptor agonists, it accelerates the development of targeted neurological therapies.
Features
One-step procedure ensures reproducibility in neurological drug screening; Sensitive detection supports investigation of cholinergic pathway modulators.
Process Relevance
Neurotoxicity Screening
Application Stage
Pre-clinical Safety
Applications
Neurobiology research for studying cholinergic signaling and neuromuscular function.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 570 nm, or Fluorescence Detection (Ex 530 nm / Em 585 nm)
Sample Type
Serum, plasma, urine, saliva, milk, tissue, cell culture, samples
Research Areas
Neuroscience; Neurodegenerative Disease
Datasheet